Navigation Links
Chi-Med Announces Positive Phase II Proof-of-Concept Data for,HMPL-004 in Ulcerative Colitis

n increase from around 300,000 patients in 2001. Potentially a further two to three times as many individuals may suffer from Ulcerative Colitis but are currently undiagnosed. Crohn’s Disease is more prevalent with an estimated 558,000 cases in the US in 2005. The US market for Ulcerative Colitis drugs was estimated to be US$420 million in 2002 and is expected to reach US$500 million by 2012, a CAGR of four percent. The US market for Crohn’s Disease drugs was estimated to be US$590 million, growing to around US$980 million by 2012. In both cases, the global market is estimated to be twice the size of the US. Global sales of Ulcerative Colitis drugs are estimated to reach US$1 billion by 2012 and, for Crohn’s Disease, the estimate is around US$2 billion. Current treatments include Aminosalicylates (5-ASAs) to reduce and control inflammation. In addition, Corticosteroids and Immunomodulators are prescribed for patients who do not respond to first line treatments.


About HMPL-004

HMPL-004 acts on multiple cellular targets in the inflammatory signal transduction pathways resulting in suppressed inflammation cytokine expression including TNF-?, IL-1? and IL-6. HMPL-004 was demonstrated to inhibit TNF-? and IL-1? production in cell-based assays. HMPL-004 is also able to inhibit NF-kB activation. NF-kB is a family of transcriptional factors that regulate a wide spectrum of genes critically involved in host defence and inflammation. The mechanism of action of HMPL-004 was further supported in inflammatory bowel disease pre-clinical models. Treatm
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:6/3/2015)... plc (NYSE: ACT ), a leading global pharmaceutical company, ... of Actavis, will provide an overview and update of the ... Conference in Rancho Palos Verdes, Calif. ... The presentation will take place on Wednesday, June 10, 2015 ... Rancho Palos Verdes, Calif.  To access a ...
(Date:6/3/2015)... CORONA, Calif. , June 3, 2015  Giving ... is the ultimate mission of the International Academy ... offer treatments and resources that are at the forefront ... eye care professionals in the technology and latest treatment ... that has not been remedied with traditional means. Recently, ...
(Date:6/3/2015)... DIEGO , June 3, 2015  OncoSec ... company developing DNA-based intratumoral cancer immunotherapies, today announced ... dedicated healthcare institutional investors to purchase approximately $13.6 ... OncoSec has agreed to sell to such investors ... stock at a price of $5.50 per share. ...
Breaking Medicine Technology:Actavis to Present at the Goldman Sachs 36th Annual Global Healthcare Conference 2International Academy of Low Vision Specialists Announces Training of Doctors in Six New States and Canada 2International Academy of Low Vision Specialists Announces Training of Doctors in Six New States and Canada 3International Academy of Low Vision Specialists Announces Training of Doctors in Six New States and Canada 4OncoSec Medical Announces $13.6 Million Registered Direct Offering 2OncoSec Medical Announces $13.6 Million Registered Direct Offering 3
... 454 Life Sciences, a Roche,company, in collaboration ... Urbana-Champaign today announced that they have uncovered ... the company,s Genome,Sequencer(TM) system, the researchers examined ... correlated different expression patterns to different,social behaviors. ...
... "Study Findings and Limitations Require Further Investigations," Says ... ... Centers for Disease Control (CDC),study on the relationship between mercury ... says one of the,study,s external consultants, Sallie Bernard, Executive Director ...
Cached Medicine Technology:454 Sequencing(TM) in Science Today: Researchers Uncover a Genetic Basis for Different Social Behaviors in Wasps 2454 Sequencing(TM) in Science Today: Researchers Uncover a Genetic Basis for Different Social Behaviors in Wasps 3Vaccine Study in New England Journal of Medicine Wrong in Concluding Mercury Exposures are Harmless, States SafeMinds 2
(Date:6/3/2015)... June 03, 2015 A recent ... precautions on product labels underscores the importance of ... to the American Society for Dermatologic Surgery Association. ... new warnings about the risks for serious injury ... While product labels already include information about risks, ...
(Date:6/3/2015)... Jersey City, NJ (PRWEB) June 03, 2015 ... enterprise collaboration across platforms and devices, announced today that ... Year Award in Collaboration and Content. The company was ... partners for demonstrating excellence in innovation and implementation of ... years winning Microsoft Partner of the Year Awards – ...
(Date:6/3/2015)... Follow us on LinkedIn ... disease treatment on account of their better mode of ... as rheumatoid arthritis. The industry is expected to witness ... molecule drugs to biopharmaceuticals over the coming years. The ... gene therapies, and recombinant proteins has attracted industry players ...
(Date:6/3/2015)... 03, 2015 Horizon Blue Cross Blue Shield ... as one of the nation’s top employers for diverse managers ... among its national list of Best Places for Diverse Managers ... No. 1 Regional Company. This is the sixth consecutive ... Magazine for its diverse workplace policies and programs. , Companies ...
(Date:6/3/2015)... 03, 2015 Justina Molzon, MS Pharm, ... at DIA’s upcoming Annual Meeting. DIA’s Global Inspire Award ... level of excellence, and commitment to service on a ... Excellence in Service Award that recognizes the “Member of ... DIA volunteer and who has contributed to the advancement ...
Breaking Medicine News(10 mins):Health News:ASDSA Supports FDA Fillers Directive 2Health News:ASDSA Supports FDA Fillers Directive 3Health News:ASDSA Supports FDA Fillers Directive 4Health News:AvePoint Wins 2015 Microsoft Partner of the Year Award for Collaboration and Content 2Health News:AvePoint Wins 2015 Microsoft Partner of the Year Award for Collaboration and Content 3Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 4Health News:Horizon Blue Cross Blue Shield of New Jersey Named a 2015 Best Place for Diverse Managers and Women to Work by Diversity MBA Magazine 2Health News:Former FDA Official and U.S. Public Health Service Officer to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 2Health News:Former FDA Official and U.S. Public Health Service Officer to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 3
... Cancer, CLEVELAND, Feb. 26 Senators Hillary ... final debate before the March 4,primaries. The candidates ... but fell short on a critical health issue ... by 62 percent of Americans as the key,health ...
... was expanding the boundaries of the well-known song My Favorite ... could have known what inspired him to take the musical ... better picture of how the brain was helping to carry ... and Other Communication Disorders (NIDCD) have found that, when jazz ...
... on Outstanding Disputes, SPOKANE, Wash., Feb. 26 ... Idaho reached settlement on four,outstanding disputes. The approximately ... Washington., "This settlement is very important for ... despite management,s refusal to negotiate a fair,contract," said ...
... NEW YORK, Feb. 26 QED International Associates, ... 20 underlying,indexes for the HealthShares(TM) Exchange-Traded Funds, today ... Friday February 29, 2008, UCB,SA (Brussels: UCB.BR) will ... HealthShares(TM) GI/Gender Health Index. Axcan Pharma is being,acquired ...
... Feb. 26 Staying healthy is as much about ... when you,re not. Now a new tool,for consumers is ... panel of experts in digestive and heart health,weight management, ... Listen to this report from Kellogg,s at:, http://media.medialink.com/WebNR.aspx?story=34684 ...
... Citing a Center for,Medicare and Medicaid Services ... over 20 percent of national health care spending ... following statement,urging the House to take up legislation ... Hoyer (D-Md.) to safeguard Medicare:, "Looking at ...
Cached Medicine News:Health News:Democratic Candidates Miss Key Health Issue in Debate 2Health News:In jazz improv, large portion of brain's prefrontal region 'takes 5' to let creativity flow 2Health News:In jazz improv, large portion of brain's prefrontal region 'takes 5' to let creativity flow 3Health News:In jazz improv, large portion of brain's prefrontal region 'takes 5' to let creativity flow 4Health News:Nurses Convince Hospital to Return to Bargaining Table 2Health News:Blunt Cites New CMS Report in Calling for Action on Safeguarding Medicare 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: